![Jonathan Aballi, President and Chief Executive Officer. [NASDAQ XGN] at Exagen](https://exagen.wpenginepowered.com/wp-content/uploads/2022/11/John-A-Headshot.png){kind=small}
DermTech
Business Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
12340 El Camino Real, San Diego, Califor...Phone Number
(858) 450-4222Website
www.dermtech.comRevenue
$15.7 MillionStock Symbol
DMTKQIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About DermTech
DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States.Explore more
DermTech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DermTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if DermTech had a recent Job posting/layoffs
Earning: See what the market has to say on DermTech recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once DermTech has new funding data
DermTech, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if DermTech is spiking on competitors!
Check if DermTech has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at DermTech
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when DermTech launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to DermTech
Compare insights from companies similar to DermTech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$60.1M
51-200
Private
$82M
2006
DV
Daniel VummagoniCorporate Development Senior VP & Chief Financial Officer
Company Profile Activity
Activity Insights
DermTech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
DermTech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about DermTech.
DermTech financials insights
Gather financial insights about DermTech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Other Financing Round
$10M
2015
Other Financing Round
$2.4M
2017
Series C
$10M
2020
Share Placement
$65M
DermTech Tech Stack
A closer look at the technologies used by DermTech
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Real Estate, Leasing, Laboratory Operations
Left Company
Executive Move
Executive Moves, Left Company
Earnings
Earnings
Sales
Earnings
Financial Planning, Intellectual Property
DermTech News & Media
DermTech 2.0 Expands DermTech Stratumâ„¢, a Non-Invasive Skin Genomics Service Offering
SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- DermTech 2.0 ("DermTech LLC" or "The Company"), a leader in precision dermatology enabled by DermTech's proprietary non-invasive Smart Sticker® skin sample collection platform, announced today the expansion of its precision biomarker service...DERMTECH: "GENOMIC ANALYSIS AIDS IN THE MANAGEMENT OF DERMOSCOPICALLY ATYPICAL PIGMENTED SKIN LESIONS"
SAN DIEGO, Oct. 9, 2024 /PRNewswire/ -- DermTech, LLC (DermTech) a leader in precision dermatology offering non-invasive skin genomics solutions, announced the publication of new data suggesting that non-invasive genomic testing can reliably differentiate melanoma in situ from...DermTech Completes Transaction for Asset Sale; Operations Continue Under New Ownership and Management
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (OTC: DMTKQ) (DermTech or the Company) a leader in precision dermatology offering non-invasive skin genomics solutions, today announced that it has closed its Asset Purchase Agreement (APA) with DERM-JES Holdings, LLC. As a result of the APA, DERM-JES Holdings, LLC has acquired substantially all assets of the Company. The new entity will operate as DermTech, LLC going forward. Led by a dedicated team of dermatologists, dermatopathologists and experiencCancer Test Company DermTech Gets 1st Day Approvals - Law360 Bankruptcy Authority
Bankrupt California-based dermatologic test maker DermTech Inc. won approval on Thursday for a series of first-day Chapter 11 motions, including to continue paying providers of electricity, internet and other utilities that power its molecular laboratory.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DermTech
Sign Up For FreeTo access detailed company insights
DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States.... Read More
